Parallel Implementing OpenGL on PVM

Wei Li,Xiaohu Huang,N. Zheng

DOI: https://doi.org/10.1016/S0167-8191(97)00090-2

IF: 0.983

1997-12-01

Parallel Computing

Abstract:

What problem does this paper attempt to address?

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma

Tianhai Lin,Zhenhua Liu,Liangren Liu,Lu Yang,Ping Han,Peng Zhang,Qiang Wei

DOI: https://doi.org/10.3892/ol.2017.5926

Abstract:Urothelial carcinoma (UC) is the most common type of cancer of the bladder and upper urinary tract, and is characterized by a high risk of recurrence and progression. Urine fluorescence in situ hybridization (FISH) is a technique that detects genetic aberrations in exfoliated cells in the urine, with specific probes for chromosomes 3, 7 and 17 and the p16 gene. To evaluate the diagnostic value of FISH in UC, 119 patients from November 2010 to June 2012 with suspected UC were recruited into a prospective, cross-sectional study and were followed up for 12-30 months. These patients received voided urine cytology and FISH tests, and underwent cystoscopy and/or ureteroscopy as a reference standard. The final diagnoses confirmed 73 patients with UC, located in the bladder, upper urinary tracts or the two. The sensitivity of FISH for detecting UC was superior to cytology, irrespective of tumor grade and stage: Overall, 80.8 vs. 32.9% (P<0.001); low grade, 75.8 vs. 12.1% (P<0.001); high grade, 85 vs. 50% (P<0.005); non-muscle-invasive, 81.1 vs. 28.3% (P<0.001) and muscle-invasive, 80 vs. 45% (P<0.05), respectively. The specificities of the two tests were similar; overall, the specificity was 89.1% for cytology vs. 100% for FISH, and no significant difference was observed between the methods. Notably, FISH exhibited 100% sensitivity for cytologically non-diagnostic UC, but 33.3% specificity. In conclusion, FISH is a reliable and non-invasive diagnostic tool for bladder and upper urinary tract UC, particularly in patients with low-grade or early stage tumors.
Visually imprinted maternal preference in ducklings is redirected by social interaction with siblings.

R. Lickliter,Gilbert Gottlieb

DOI: https://doi.org/10.1002/DEV.420190312

1986-05-01

Developmental Psychobiology

Abstract:This study examined the influence of social interaction with broodmates on a visually imprinted maternal preference in domestic mallard ducklings (Anas platyrhynchos) during the first three days of postnatal life. Twenty-four-hour-old ducklings were allowed to follow a stuffed mallard hen for 30 min. This experience resulted in a visually imprinted preference for the familiar stuffed hen over 4 stuffed ducklings in simultaneous choice tests at 48 and 72 hr after hatching, but only if the imprinted birds were kept in social isolation. Imprinted ducklings reared in a social group containing either same-age siblings or the stuffed mallard hen and same-age siblings displayed a visual preference for the stuffed ducklings over the familiar mallard hen at 48 and 72 hr tests. As a first step in the analysis of the features of the social exposure to siblings that are necessary for the redirection of the visually imprinted maternal preference, it was found that direct social interaction is essential to establish the preference for ducklings, but even mere visual exposure to siblings does away with the imprinted maternal preference. These results provide striking evidence of the ready redirection of a species-specific maternal preference in otherwise imprinted ducklings.
Does aortocoronary saphenous vein bypass surgery change the native coronary arteries? An angiographic follow-up of 60 patients.

S. Nitter‐Hauge,K. Levorstad

DOI: https://doi.org/10.1111/J.0954-6820.1980.TB09703.X

2009-04-24

Acta Medica Scandinavica

Abstract:. Progression of disease in the native coronary circulation was studied in 60 patients before and after aortocoronary saphenous vein bypass surgery. The mean interval between the first angiographic study and operation was 2.0 months and the mean interval from operation to second catheterization was 15.3 months. The results from a second arteriographic study after an interval of 12.3 months on 25 comparable patients, with no surgery in between, served as a control material for frequency and severity of the “natural” progression of the disease. Only vessels which were not occluded at the first examination were included in the re-study. In the 60 operated patients, 106 arteries were grafted and 74 ungrafted. Total graft patency at the time of re-study was 66%. Progression was found in segments proximal to the anastomosis in 42% of arteries with patent graft, and in 47% of arteries with occluded graft, whereas in segments distal to the site of anastomosis progression was found in 5% of the arteries with patent graft and in 55% of arteries with occluded graft. Progression of the disease was found in 11% of ungrafted arteries. In the control group, progression of the disease was found in 24%. The study thus shows that after aortocoronary bypass surgery, progression in segments proximal to the anastomosis is significantly higher than in nongrafted arteries. The progression was independent of patency or occlusion of the graf to the vessel. Progression in the segments distal to the anastomosis was not significantly different from the frequency of progression seen in nongrafted arteries if the graft was patent, but was much higher if the graft was occluded.
Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma]

Da-wei Mu,Li-qun Zhou,Yi Ding,Zhi-song He,Ying Wang,Qun He,Xin-yu Yang

DOI: https://doi.org/10.3969/j.issn.1671-167x.2010.04.005

2010-01-01

Abstract:To assess the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasive method for diagnosing and monitoring urothelial carcinoma (UC) in the upper urinary tract (UUT).Urine specimens from 63 consecutive patients with UUT-UC and 69 controls with benign disease were analyzed by means of cytology and FISH. For FISH analysis, labeled probes specific for chromosomes 3, 7, and 17 and for the p16 (9p21) gene were used to assess chromosomal abnormalities indicative of malignancy.Sensitivity and specificity of both techniques were determined and compared. The frequency of chromosomal aberrations of malignant cells from UUT-UC was also determined.Of 63 patients with UUT-UC, FISH affords an overall sensitivity of 84.1% (53/63), the figure being 71.4% (20/28) for PTa and PT1 tumors,94.3% (33/35) for PT2-4 tumors. The sensitivities of urine cytology were 35.7% (10/28) for PTa and PT1 tumor,45.7% (16/35)for PT2-4 tumors,with an overall sensitivity of 41.3% (26/63). The sensitivities of the two methods for the low grade tumors were 80% (20/25) and 44% (11/25), and for high grade tumors were 86.8% (33/38) and 39.5% (15/38), respectively. Specificities for FISH and urine cytology were 91.3% (63/69) and 94.2% (65/69)respectively.According to the results,the sensitivity of FISH for the detection of UUT-UC is superior to that of urine cytology and the specificities of FISH and urine cytology are not significantly different. FISH can promote the diagnosis of UUT-UC, especially for the low stage and low grade cases,it may be a new promising non-invasive method for the diagnosis of UUT-UC.
Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer

Guanghou Fu,Kok Suen Cheng,Anqi Chen,Zhijie Xu,Xiaoyi Chen,Junjie Tian,Congcong Xu,Yukun Sun,Kuang Hong Neoh,Yun Dai,Ray P. S. Han,Baiye Jin

DOI: https://doi.org/10.3389/fonc.2021.701298

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:Bladder cancer is characterized by its frequent recurrence and progression. Effective treatment strategies need to be based on an accurate risk stratification, in which muscle invasiveness and tumor grade represent the two most important factors. Traditional imaging techniques provide preliminary information about muscle invasiveness but are lacking in terms of accuracy. Although as the gold standard, pathological biopsy is only available after the surgery and cannot be performed longitudinally for long-term surveillance. In this work, we developed a microfluidic approach that interrogates circulating tumor cells (CTCs) in the peripheral blood of bladder cancer patients to reflect the risk stratification of the disease. In a cohort of 48 bladder cancer patients comprising 33 non-muscle invasive bladder cancer (NMIBC) cases and 15 muscle invasive bladder cancer (MIBC) cases, the CTC count was found to be considerably higher in the MIBC group compared with the NMIBC group (4.67 vs. 1.88 CTCs/3 mL, P=0.019), and was significantly higher in high-grade bladder cancer patients verses low-grade bladder cancer patients (3.69 vs. 1.18 CTCs/3mL, P=0.024). This microfluidic assay of CTCs is believed to be a promising complementary tool for the risk stratification of bladder cancer.
The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma

Haijiang Zhou,Yong Yan,Liming Song

DOI: https://doi.org/10.7754/Clin.Lab.2016.160323

2016-10-01

Abstract:Background: Chromosomal aberrations in exfoliated urothelial cells have been associated with the development of urothelial carcinoma. This study aimed to evaluate the efficacy of two kinds of fluorescence in situ hybridization (FISH) kit probes in diagnosing urothelial carcinoma (UC). Methods: From February 2009 through September 2014, urine specimens from 89 consecutive patients with urothelial carcinoma and 11 controls with benign disease were collected and analyzed by means of GP FISH and cytology. Urine samples from 50 consecutive patients with urothelial carcinoma and 68 patients with non-urothelial carcinoma with hematuria were also collected and analyzed by UroVysion FISH and cytology. The sensitivity and specificity of two kinds of FISH and cytology in different stages and grades of urothelial carcinoma were statistically analyzed via SPSS 17.0 and compared. Results: The overall sensitivity of GP FISH and cytology were 88.8% (79/89) and 55.1% (49/89), respectively (p < 0.001), and the overall specificity was 90.9% (10/11) and 100.0% (11/11), respectively (p > 0.05). The overall sensitivity of UroVysion FISH and cytology was 68.0% and 18.0%, respectively (p < 0.05), and the overall specificity was 91.2% and 98.5%, respectively (p > 0.05). The sensitivity of FISH and cytology in diagnosing UUT-UC were 88.9% (16/18) and 44.4%(8/18),respectively. The sensitivity of GP FISH and UroVysion FISH in diagnosing UUT-UC were 100% (10/10) and 75.0% (6/8) respectively. Conclusions: FISH is a non-invasive technique with higher sensitivity and similar specificity compared with urine exfoliated cell cytology in diagnosing urothelial carcinoma by detecting the aberrations of chromosome 3, 7, 17, and 9p21. FISH is significantly superior to cytology in diagnosing low stage and low grade urothelial carcinomas. FISH is a very valuable and promising technique in diagnosing urothelial carcinomas.
Application of Double Fluorescence in Situ Hybridization Technology in the Diagnosis of Bladder Urothelial Carcinoma

LIU Hong,ZHANG Yang-de,LIU Xing-yan,GAO Xin

DOI: https://doi.org/10.3969/j.issn.1005-8982.2010.10.012

2010-01-01

Abstract:[Objective]To evaluated the performance of a dual-color FISH (fluorescence in situ hybridization) assay for urothelial carcinoma (UC) of the bladder, in comparison to urinary cytology[.Methods]Fluorescence in situ hybridization (FISH) was performed using centromeric probes of chromosome 7, 9, 17 and 9p21 region to examine chromosome aberration of exfoliated cells in 78 urine samples from patients with urothelial carcinoma (UC) of the bladder, 30 urine samples from healthy control. All of the samples were analyzed by urinary cytology at the same time[.Results]The sensitivity of urine cytology for Ta, T1 and T2-T4 tumors was 35.5% (11/31), 54.1 %(13/24) and 69.6% (16/ 23), respectively, for an overall sensitivity of 51.6%. The sensitivity of FISH for Ta, T1 and T2-T4 tumors was 64.5% (20/31), 87.5% (21/24) and 95.7% (22/23), respectively, for an overall sensitivity of 80.8%. FISH was significantly more sensitive than cytology for T1 (P =0.047), T2-T4 (P =0.0235), grade Ⅱ (P =0.004), grade Ⅲ(P =0. 002) and all tumors (P =0.001). The specificity of cytology and FISH was 98% and 96%, respectively (P =0.612)[.Conclusion] The sensitivity of FISH for the detection urothelial carcinoma (UC) of the bladder is superior to that of cytology, and the specificity of FISH and cytology for urinary bladder cancer are not significantly different. FISH can improve significantly the diagnosis of urinary bladder cancer and will be significant for screening of urinary bladder cancer.
Microfluidic Assaying of Circulating Tumor Cells and its Correlation with Muscle Invasiveness and Tumor Grade of Urothelial Bladder Cancer

Guanghou Fu,Kok Suen Cheng,Anqi Chen,Zhijie Xu,Xiaoyi Chen,Junjie Tian,Congcong Xu,Yukun Sun,Kuang Hong Neoh,Yun Dai,Ray P.S. Han,Baiye Jin

DOI: https://doi.org/10.21203/rs.3.rs-267304/v1

2021-01-01

Abstract:Abstract Background: Bladder cancer is characterized by its frequent recurrence and progression. Effective treatment strategies need to be based on an accurate risk stratification, in which muscle invasiveness and tumor grade represent the two most important factors. Traditional imaging techniques provide preliminary information about muscle invasiveness but are lacking in terms of accuracy. Although as the gold standard, pathological biopsy is only available after the surgery and cannot be performed longitudinally for long-term surveillance. Methods: In this work, we developed a microfluidic approach that interrogates circulating tumor cells (CTCs) in the peripheral blood of bladder cancer patients to reflect the risk stratification of the disease. Results：In a cohort of 48 bladder cancer patients comprising 33 non-muscle invasive bladder cancer (NMIBC) cases and 15 muscle invasive bladder cancer (MIBC) cases, the CTC count was found to be considerably higher in the MIBC group compared with the NMIBC group (4.67 vs. 1.88 CTCs/3 mL, P=0.019), and was significantly higher in high-grade bladder cancer patients verses low-grade bladder cancer patients (3.69 vs. 1.18 CTCs/3mL, P=0.024). Conclusions: This microfluidic assay of CTCs is believed to be a promising complementary tool for the risk stratification of bladder cancer.Trial registration: This research was conducted under the approval of the Ethics Committee of the First Affiliated Hospital at Zhejiang University School of Medicine with the Registration No. 2015-218.
Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results

Teresa McHale,N Paul Ohori,Kathy M Cieply,Carol Sherer,Sheldon I Bastacky

DOI: https://doi.org/10.1002/dc.24108

Abstract:Background: We examine the performance of cytology and FISH in the detection of urothelial carcinoma (UC), and explore the reasons for discrepant results, and potential clinical implications. Methods: Urine samples from 89 patients were prospectively collected for simultaneous cytology and UroVysion FISH, and results correlated with concurrent biopsies and/or clinical or histologic follow-up data. Corresponding tissue biopsies, where available, were also evaluated by FISH. Results: Sensitivity and specificity of cytology and FISH for the detection of UC was 54.8% and 92% and 50% and 88%, respectively. Only one of seven false-positive urinary FISH results proved to be an "anticipatory positive" on extended follow-up. Five of eight (62.5%) high grade (HG) carcinomas with false-negative urinary FISH, were negative due to the absence/paucity of FISH-detectable changes in the tumor cells. In atypical cytology cases, the FISH result did not assist in identifying UC. There was no significant difference between an atypical cytology result and a positive FISH result, with respect to the identification of patients with UC. Conclusions: We found urinary cytology to be more sensitivity and specific than FISH in the detection of UC, though the difference was not statistically significant. Up to 24% of HG UCs are FISH negative due to an absence of FISH-detectable abnormalities in the tumor cells. Paucity of neoplastic cells in the urine also contributes to false-negative FISH results in both HG and low grade tumors. Negative urinary FISH cannot be taken alone as indicating the absence of significant disease in patients with atypical cytology.
Emergency department management of pediatric patients with cyanotic heart disease and fever.

C. Tibbles,M. Bouton,J. Lucas,M. Harper,C. Horwitz,J. Fisher

DOI: https://doi.org/10.1016/j.jemermed.2012.09.030

IF: 1.473

2013-03-01

Journal of Emergency Medicine

Abstract:
The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas

Xueqi Sun,Xubin Liu,Meng Xia,Shicong Yang,Lingyan Fei,Mengqi Zhang,Hanyu Ma,Liantang Wang,Shangwu Chen,Li Yu

DOI: https://doi.org/10.1002/dc.23796

Abstract:Objectives: To evaluate the diagnostic values of urine liquid-based cytology (LBC), fluorescence in situ hybridization (FISH), and p16/Ki-67 dual immunostaining in the detection of upper tract urothelial carcinomas (UTUCs). Methods: Sixty-one patients with UTUCs were retrospectively analyzed. All patients were diagnosed both by urine cytology and by FISH, and histologically confirmed as UTUCs. Thirty-two patients had been stained with p16/Ki-67 dual labeling. Results: The sensitivities for low-grade UTUCs (LGUTUCs) and high-grade UTUCs (HGUTUCs) were 33.3% and 67.4% by LBC, 60% and 69.6% by FISH, and 12.5% and 66.7% by p16/Ki-67 dual labeling, respectively. Conclusions: Our results indicated that LBC was more suitable to identify HGUTUCs, FISH was highly valuable for predicting LGUTUCs, and p16/Ki-67 dual labeling was useful for distinguishing HGUTUCs from LGUTUCs. The combined application of these methods may improve the sensitivity or accuracy in the detection or diagnosis of UTUCs.
Saturable, "carrier-mediated", absorption of prostaglandin F2 alpha from the in vivo rabbit vagina and its inhibition by prostaglandin F2 beta.

L. Bito,P. Spellane

Prostaglandins

Abstract:
Clinical utility of fluorescence in situ hybridization assay for urothelial carcinoma and analysis of reasons of missed diagnosis

Qing YE,Zhi-hua WANG,Jun YANG,Feng QU,Fan-qing MENG

DOI: https://doi.org/10.13315/j.cnki.cjcep.2011.08.019

2011-01-01

Abstract:Purpose Urothelial carcinoma is a common malignant neoplasm of the genitourinary system.The purpose of this study was to evaluate the specificity and sensitivity of fluorescence in situ hybridization(FISH) assay as a non-invasive method for diagnosis and surveillance of urothelial carcinoma(UC) and to analysis primary reasons of missed diagnosis.Methods UC-related aneuploidy of chromosome 9p21 and 3,7,17 were analyzed using uroepithelial cells at the first void urine for patients with suspected urinary tract tumor or suspected recurrent UC.Uroepithelial cells in urine were tested by FISH and tumor tissue cystoscopy biopsy or operation was employed by histology simultaneously.The sensitivity and specificity were calculated based on the histology correlation.For those missed-diagnosis cases,FISH was used to analyze chromosomes 9p21 and 3,7 and 17 in related tumor tissue,and urine cytology.The primary reasons of misdiagnosis were analyzed.Results Among 100 patients with pathological diagnosis,35 patients were urothelial carcinoma(UC),and 65 patients were non-carcinoma.The sensitivity and specificity of FISH were 80%(28/35) and 100%(65/65),respectively.FISH identified 25 positive cases in 28 high-grade urothelial carcinoma cases(sensitivity 89.29%);while the 3 missed diagnosis cases showed UC-related genetic abnormalities in tumor tissue but in exfoliocytology with few urothelial cells.Among 7 low-grade urothelial carcinoma cases,FISH identified 3 positive cases(sensitivity 42.86%);while the 2 of 4 missed diagnosis cases showed a small amount of aneuploidy tumor cells in tumor tissue by FISH but in exfoliocytology with few urothelial cells;Another 2 of 4 missed diagnosis cases showed no UC-related genetic abnormalities in tumor tissue and in exfoliocytology.Conclusion It is an effective method for diagnosis and surveillance in UC to detect UC-related aneuploidy of chromosomes 9p21 and 3,7,and 17 by FISH in the urine exfoliated cells.This detection is more sensitive for the high-grade urothelial carcinoma cases.The main cause of misdiagnosis may be few urothelial cells in urine of high-grade urothelial carcinoma or lack of UC-related aneuploidy for low-grade urothelial carcinoma.
Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma

Stefan Pycha,Emanuela Trenti,Christine Mian,Christine Schwienbacher,Esther Hanspeter,Margherita Palermo,Armin Pycha,Hansjörg Danuser,Carolina D'Elia

DOI: https://doi.org/10.1007/s00345-023-04350-x

Abstract:Purpose: Following the current guidelines, diagnosis and staging for upper urinary tract tumours (UTUC) can be performed with Computed Tomography, urography, ureterorenoscopy (URS) and selective cytology. The aim of the study was to evaluate the performance of the Xpert®-BC-Detection and the Bladder-Epicheck®-test in the detection of UTUC and compare it with cytology and the Urovysion®-FISH test using histology and URS as gold standard. Methods: A total of 97 analyses were collected through selective catheterization of the ureter before URS to test for cytology, Xpert®-BC-Detection, Bladder-Epicheck® and Urovysion®-FISH. Sensitivity, specificity, and predictive values were calculated using histology results/URS as reference. Results: Overall sensitivity was 100% for Xpert®-BC-Detection, 41.9% for cytology, 64.5% for Bladder-Epicheck® and 87.1% for Urovysion®-FISH. The sensitivity of Xpert®-BC-Detection was 100% in both, LG and HG tumours, sensitivity of cytology increased from 30.8% in LG to 100% in HG, for Bladder-Epicheck® from 57.7% in LG to 100% in HG and of Urovysion®-FISH from 84.6% in LG to 100% in HG tumours. Specificity was 4.5% for Xpert®-BC-Detection, 93.9% for cytology, 78.8% for Bladder-Epicheck® and 81.8% for Urovysion®-FISH. PPV was 33% for Xpert®-BC-Detection, 76.5% for cytology, 58.8% for Bladder-Epicheck® and 69.2% for Urovysion®FISH. NPV was 100% for Xpert®-BC-Detection, 77.5% for cytology, 82.5% for Bladder-Epicheck® and 93.1% for Urovysion®FISH. Conclusion: Bladder-Epicheck® and Urovysion®FISH along with cytology could be a helpful ancillary method in the diagnosis and follow-up of UTUC while due to its low specificity Xpert®-BC Detection seems to be of limited usefulness.
Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma

Tilman Todenhöfer,Jörg Hennenlotter,Michael Esser,Sarah Mohrhardt,Veronika Tews,Stefan Aufderklamm,Georgios Gakis,Ursula Kuehs,Arnulf Stenzl,Christian Schwentner

DOI: https://doi.org/10.1002/cncy.21247

Abstract:Background: The sensitivity of cytology for the detection of urothelial carcinoma (UC) is limited. Newer methods such as fluorescence in situ hybridization (FISH), immunocytology (uCyt+), and protein markers have been developed to improve urine-based detection of UC. As only little is known regarding the combined application of these markers, we investigated whether combinations of 4 of the most broadly available tests (cytology, FISH, uCyt+, and nuclear matrix protein 22 [NMP22-ELISA]) may improve their diagnostic performance. Methods: The study was comprised of 808 patients who were suspected of having UC. All patients underwent urethrocystoscopy and upper urinary tract imaging and, in the case of positive findings, transurethral resection/biopsy. FISH, uCyt+, cytology, and NMP22-ELISA were performed in all patients. Results: UC was diagnosed in 115 patients (14.2%). Cytology and FISH were found to be the single tests with the best overall performance (area under the curve [AUC], 0.78/0.79). Combinations of 2, 3, and 4 markers were found to increase the AUC to various extents compared with the use of single markers. Combining cytology and FISH improved the sensitivity and performance (AUC, 0.83) compared with the single tests and identified 12 tumors that were not detected by cytology alone. The percentage of WHO grade 3/carcinoma in situ tumors not detected by cytology was reduced by 62.5% when FISH was performed in cytology-negative patients. The addition of uCyt+ as a third test further improved performance (AUC, 0.86), whereas the addition of NMP22-ELISA was not found to have any additional influence on the performance of the test combination. Conclusions: The results of the current study support the combined use of urine markers and may form the basis of further studies investigating whether risk stratification based on urine marker combinations may individualize diagnostic algorithms and the surveillance of patients suspected of having UC.
UroVysionTM fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages

Chunjin Ke,Xuguang Liu,Jie Wan,Zhiquan Hu,Chunguang Yang

DOI: https://doi.org/10.3389/fmolb.2023.1250442

IF: 6.113

2023-10-06

Frontiers in Molecular Biosciences

Abstract:Background: Positive UroVysion TM fluorescence in situ hybridization (FISH) is generally considered as urothelial carcinoma (UC). We clarify if UroVysion TM FISH can be positive in carcinoma of non-urothelial lineages (CNUL), and verify the consistency of urine FISH and histological FISH in CNUL. Methods: All CNUL subjects detected by urine FISH assay due to haematuria from Tongji Hospital were screened. Meanwhile, 2 glandular cystitis and 2 urothelial carcinoma were served as negative or positive control. Paraffin-embedded tissue sections of all subjects were sent to the pathology department for histological FISH detection. Results: A total of 27 patients were included in this study, including 9 with adenocarcinomas, 11 with squamous cell carcinomas, and 7 with other tumour types. The overall positive rate in urine FISH was 64.00% (16/25) in patients with CNUL, 77.78% (7/9) in those with adenocarcinoma and 54.55% (6/11) in those with squamous carcinoma. There was a significant difference in the GLP p16 gene deletion rate between UC and CNUL (100% vs. 8.00%, p = 0.017). Histological FISH results showed that the histological results of 19 patients were consistent with their urine FISH results, and only one patient with stage IIIa urachal carcinoma had inconsistent histological FISH results (positive) and urine FISH (negative) results. Conclusion: We demonstrated for the first time the application value of FISH in CNUL on urine samples. Positive urine FISH tests indicate not only UC, but also CNUL. UroVysion TM FISH possibly has a high positive rate in CNUL. CNUL and UC have different genetic changes shown by FISH.

biochemistry & molecular biology
The clinical application of fluoresence in situ hybridization in diagnosis of urothelial bladder cancer

YUAN xiao-liang,GAN Wei-dong,YAO Lin-fang,YAN Xiang,LIU Tie-shi,QU Feng,ZHAO Xiao-zhi,YANG Rong,LI Xiao-gong,ZHANG Gu-tian,ZHANG Shi-wei,GUO Hong-qian

DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2012.01.014

2012-01-01

Abstract:Objective To evaluate the value of fluorescence in situ hybridization (FISH) in diagnosis of urothelial bladder cancer. Methods Twenty specimens were obtained from healthy people. Using directly labeled DNA probes of the 3rd, 7th, 17th and P16 dot at 9th chromosome to detect the exfoliated urothelial cells in the urine. And get the threshold value of healthy adult. Fresh urine samples from 158 patients who were suspected of bladder carcinoma were collected and examined by cytology and fish simultaneously before cystoscopy. The sensitivity and specificity of FISH and cytology were analyzed. Results The sensitivity of FISH and cytology was 84.8% and 43.8%. The sensitivity of FISH was prior to that of cytology (P<0.05), the specificity of FISH and cytology was 89.1% and 87.0%(P>0.05). In different tumor pathologic grade and clinical stuns, FISH got a higher sensitivity than cytology, which gradually increased following with increasing tumor pathologic grade(P<0.05). Conclusions FISH has high sensitivity and specificity in diagnosing urothelial bladder cancer, it may be a new method to screen and diagnose bladder cancer in Chinese people in the future.
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial

Junlong Wu,Yuda Lin,Kaiwei Yang,Xiao Liu,Huina Wang,Tingting Yu,Ran Tao,Jing Guo,Libin Chen,Huanqing Cheng,Feng Lou,Shanbo Cao,Wei Yu,Hailong Hu,Dingwei Ye

DOI: https://doi.org/10.1186/s12943-024-01974-4

2024-03-19

Abstract:Urine-based testing is promising for noninvasive diagnosis of urothelial carcinoma (UC) but has suboptimal sensitivity for early-stage tumors. Herein, we developed a multitarget urine tumor DNA test, UI-Seek, for UC detection and evaluated its clinical feasibility. The prediction model was developed in a retrospective cohort (n = 382), integrating assays for FGFR3 and TERT mutations and aberrant ONECUT2 and VIM methylation to generate a UC-score. The test performance was validated in a double-blinded, multicenter, prospective trial (n = 947; ChiCTR2300076543) and demonstrated a sensitivity of 91.37% and a specificity of 95.09%. The sensitivity reached 75.81% for low-grade Ta tumors and exceeded 93% in high-grade Ta and higher stages (T1 to T4). Simultaneous identification of both bladder and upper urinary tract tumors was enabled with sensitivities exceeding 90%. No significant confounding effects were observed regarding benign urological diseases or non-UC malignancies. The test showed improved sensitivities over urine cytology, the NMP22 test, and UroVysion FISH alongside comparable specificities. The single-target accuracy was greater than 98% as confirmed by Sanger sequencing. Post-surgery UC-score decreased in 97.7% of subjects. Overall, UI-Seek demonstrated robust performance and considerable potential for the early detection of UC.
Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population

Liqun Zhou,Kaiwei Yang,Xuesong Li,Yi Ding,Dawei Mu,Hanzhong Li,Yong Yan,Jinyi Li,Dongwen Wang,Wei Li,Yulong Cong,Jiangping Gao,Kewei Ma,Yajun Xiao,Sheng Zhang,Hongyi Jiang,Weilie Hu,Qiang Wei,Xunbo Jin,Zhichen Guan,Qingyong Liu,Danfeng Xu,Xin Gao,Yongguang Jiang,Weimin Gan,Guang Sun,Qing Wang,Yanhui Liu,Jianquan Hou,Liping Xie,Xishuang Song,Fengshuo Jin,Jiafu Feng,Ming Cai,Zhaozhao Liang,Jie Zhang,Dingwei Ye,Lin Qi,Lulin Ma,Jianzhong Shou,Yuping Dai,Jianyong Shao,Ye Tian,Shizhe Hong,Tao Xu,Chuize Kong,Zefeng Kang,Yuexin Liu,Xun Qu,Benkang Shi,Shaobin Zheng,Yi Lin,Shujie Xia,Dong Wei,Jianbo Wu,Weiling Fu,Zhiping Wang,Jianbo Liang

DOI: https://doi.org/10.1016/j.ajur.2018.06.001

Abstract:Objective: To evaluate the diagnostic value of fluorescence in situ hybridization (FISH) in bladder cancer. Methods: We enrolled healthy volunteers and patients who were clinically suspected to have bladder cancer and conducted FISH tests and cytology examinations from August 2007 to December 2008. Receiver operating characteristic (ROC) curve analysis was performed and the area under curve (AUC) values were calculated for both the FISH and urine cytology tests. Results: A cohort of 988 healthy volunteers was enrolled to establish a reference range for the normal population. A total of 4807 patients with hematuria were prospectively, randomly enrolled for the simultaneous analysis of urine cytology, FISH testing, and a final diagnosis as determined by the pathologic findings of a biopsy or a surgically-excised specimen. Overall, the sensitivity of FISH in detecting transitional-cell carcinoma was 82.7%, while that of cytology was 33.4% (p < 0.001). The sensitivity values of FISH for non-muscle invasive and muscle invasive bladder transitional-cell carcinoma were 81.7% and 89.6%, respectively (p = 0.004). The sensitivity values of FISH for low and high grade bladder cancer were 82.6% and 90.1%, respectively (p = 0.002). Conclusion: FISH is significantly more sensitive than voided urine cytology for detecting bladder cancer in patients evaluated for gross hematuria at all cancer grades and stages. Higher sensitivity using FISH was obtained in high grade and muscle invasive tumors.
Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study

Xin Wang,Shiwei Zhang,Lang Wu,Baofu Feng,Hongwei Shen,Yuanyuan Gu,Qun Zhang,Feng Fang,Rong Yang,Hongqian Guo

DOI: https://doi.org/10.1186/s12894-022-01122-4

2022-11-25

Abstract:Background: Noninvasively urine-based diagnostic modalities for upper urinary tract urothelial carcinoma (UTUC) were still lacking. We evaluated the diagnostic value of our previously developed urine-based assay (UTC assay) in UTUC. Methods: We retrospectively analyzed 90 patients with suspected UTUC and 40 donors without UTUC. Voided urine specimens were analyzed by UTC assay and fluorescence in situ hybridization (FISH). The performance of UTC assay and FISH was compared among the 60 histologically proven UTUC patients and the 40 donors with benign disease. Results: Of the 60 UTUCs, there were 8 low-grade and 52 high-grade cases. Overall sensitivity for UTC assay and FISH were 85% and 73.3%, respectively (P = 0.116). Specificities for UTC assay and FISH were 92.5% and 95%, respectively (P = ns.). By grade, sensitivities of UTC assay and FISH were 87.5% vs. 37.5% for low-grade (P = 0.119), and 84.6% vs. 78.8% for high- grade UTUC (P = 0.446), respectively. By stage, UTC assay showed significantly higher sensitivity than FISH for detecting non-muscle-invasive UTUC, which were 88.5% vs. 61.5%, respectively (P = 0.025). Conclusion: UTC assay has good performance for the non-invasive diagnosis of UTUC. UTC assay may improve the diagnosis and surveillance of low-grade or superficial UTUC.

Parallel Implementing OpenGL on PVM

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma

Visually imprinted maternal preference in ducklings is redirected by social interaction with siblings.

Does aortocoronary saphenous vein bypass surgery change the native coronary arteries? An angiographic follow-up of 60 patients.

Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma]

Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer

The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma

Application of Double Fluorescence in Situ Hybridization Technology in the Diagnosis of Bladder Urothelial Carcinoma

Microfluidic Assaying of Circulating Tumor Cells and its Correlation with Muscle Invasiveness and Tumor Grade of Urothelial Bladder Cancer

Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results

Emergency department management of pediatric patients with cyanotic heart disease and fever.

The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas

Saturable, "carrier-mediated", absorption of prostaglandin F2 alpha from the in vivo rabbit vagina and its inhibition by prostaglandin F2 beta.

Clinical utility of fluorescence in situ hybridization assay for urothelial carcinoma and analysis of reasons of missed diagnosis

Diagnostic value of Xpert® BC Detection, Bladder Epicheck®, Urovysion® FISH and cytology in the detection of upper urinary tract urothelial carcinoma

Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma

UroVysionTM fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages

The clinical application of fluoresence in situ hybridization in diagnosis of urothelial bladder cancer

Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial

Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population

Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study